Feb 16, 2024
January 26, 2025
This week’s newsletter included:
- Merit Medical Receives FDA Clearance for SCOUT® MD™ Surgical Guidance System
- Halia Therapeutics Initiates Phase II Clinical Trial
- David Bearss to Present at BIO’s CEO & Investor Conference
- Utah Business 2024 HR Achievement Awards Nominations Open
- Metrodora Institute and PrecisionLife Partner to Accelerate Diagnosis and Treatment of Long COVID, ME/CFS, and other Chronic Conditions
- SPIRE Technology Featured in a Selective Peer-reviewed Journal
- BioUtah’s Kelvyn Cullimore to be Panelist at 2024 One Utah Summit
- Merrimack Reports Ipsen Announcement of Approval By The FDA
- Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health
- Legislative Recap
- New Resource Launched for Utah Entrepreneurs
Featured New Member: Liquidyne
Recent News
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
- RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS
